NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
1.900
-0.060 (-3.06%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NewGenIvf Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 4.73 | 5.43 | 5.14 | 5.94 | 4.12 |
| Revenue Growth (YoY) | -13.01% | 5.79% | -13.59% | 44.34% | - |
| Cost of Revenue | 3.77 | 3.61 | 3.45 | 4.41 | 3.09 |
| Gross Profit | 0.96 | 1.83 | 1.68 | 1.54 | 1.02 |
| Selling, General & Admin | 11.68 | 2.99 | 1.64 | 1.14 | 0.83 |
| Operating Expenses | 11.68 | 2.99 | 1.64 | 1.14 | 0.83 |
| Operating Income | -10.73 | -1.16 | 0.04 | 0.4 | 0.2 |
| Interest Expense | -0.62 | -0.78 | -0.05 | -0.08 | -0.09 |
| Interest & Investment Income | 0 | 0.01 | 0 | 0 | 0 |
| Other Non Operating Income (Expenses) | 0.16 | 0.97 | 0.11 | 0.02 | 0.05 |
| EBT Excluding Unusual Items | -11.18 | -0.96 | 0.11 | 0.34 | 0.16 |
| Gain (Loss) on Sale of Investments | -0.7 | - | - | - | - |
| Gain (Loss) on Sale of Assets | -0.05 | - | - | - | - |
| Other Unusual Items | 21.65 | - | - | - | - |
| Pretax Income | 9.73 | -0.96 | 0.11 | 0.34 | 0.16 |
| Income Tax Expense | - | -0.49 | - | 0.21 | 0.29 |
| Earnings From Continuing Operations | 9.73 | -0.47 | 0.11 | 0.14 | -0.14 |
| Minority Interest in Earnings | 0.15 | -0.05 | 0.02 | 0.32 | 0.14 |
| Net Income | 9.88 | -0.52 | 0.13 | 0.46 | -0 |
| Net Income to Common | 9.88 | -0.52 | 0.13 | 0.46 | -0 |
| Net Income Growth | - | - | -71.61% | - | - |
| Shares Outstanding (Basic) | 0 | - | - | - | - |
| Shares Outstanding (Diluted) | 3 | - | - | - | - |
| EPS (Basic) | 214.73 | - | - | - | - |
| EPS (Diluted) | 3.04 | - | - | - | - |
| Free Cash Flow | -11.06 | -8.32 | -1.84 | 1.62 | 1.42 |
| Free Cash Flow Per Share | -3.40 | - | - | - | - |
| Gross Margin | 20.22% | 33.62% | 32.74% | 25.87% | 24.88% |
| Operating Margin | -226.95% | -21.36% | 0.82% | 6.71% | 4.83% |
| Profit Margin | 209.03% | -9.66% | 2.54% | 7.72% | -0.01% |
| Free Cash Flow Margin | -234.03% | -153.08% | -35.75% | 27.19% | 34.39% |
| EBITDA | -10.54 | -1.14 | 0.07 | 0.5 | 0.37 |
| EBITDA Margin | -222.97% | -21.00% | 1.43% | 8.40% | 8.88% |
| D&A For EBITDA | 0.19 | 0.02 | 0.03 | 0.1 | 0.17 |
| EBIT | -10.73 | -1.16 | 0.04 | 0.4 | 0.2 |
| EBIT Margin | -226.95% | -21.36% | 0.82% | 6.71% | 4.83% |
| Effective Tax Rate | - | - | - | 60.51% | 188.70% |
Source: S&P Capital IQ. Standard template.
Financial Sources.